G. Millaki

Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status

D. Mavroudis, V. Georgoulias, M. Perraki, 2006, Breast Cancer Research.

Safety and immunogenicity of the optimized cryptic peptide TERT572Y in patients with advanced malignancies: A Phase I clinical study

I. Miconnet, M. Spiropoulou, P. Kanellou, 2005 .

Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status

D. Mavroudis, V. Georgoulias, M. Perraki, 2006, Breast Cancer Research.